Busch Matthew C.

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Busch Matthew C.'s trades of Amgen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Amgen Inc (AMGN)
Transaction date
Sale
Price
164.47
Quantity 44,435 -11.2%
Value US$467,629
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
383.23
Quantity 52,598
Value US$245,003
US Amgen Inc (AMGN)
Transaction date
Sale
Price
252.56
Quantity 20,548 -2.2%
Value US$1,073,883
US Amgen Inc (AMGN)
Transaction date
Proposed sale
Price
281.44
Quantity 1,000
Value US$281,440
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-20 2026-02-19
US Amgen Inc (AMGN)
S Sale
44,435 -11.2%
164.47
US$467,629 		44,435 -11.2% 164.47 US$467,629
2026-02-19 2026-02-19
US Amgen Inc (AMGN)
PrS Proposed sale
52,598
383.23
US$245,003 		52,598 383.23 US$245,003
2025-05-06 2025-05-02
US Amgen Inc (AMGN)
S Sale
20,548 -2.2%
252.56
US$1,073,883 		20,548 -2.2% 252.56 US$1,073,883
2025-05-02 2025-05-02
US Amgen Inc (AMGN)
PrS Proposed sale
1,000
281.44
US$281,440 		1,000 281.44 US$281,440